Legal 500
Log in or register
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR

© 2026 Legalease Ltd. All rights reserved

Registered company in England & Wales No. 02427356 VAT GB 321 5727 22

Registered address: 188 Fleet Street, London, EC4A 2AG

  • Legal 500 Trust Centre
  • Contact Us
  • home
  • Market Intelligence
  • Search

3,511 results found

Use advanced search filters to refine your search

2 filters applied

Advanced search filters

Topics
Countries
Contributor

Start typing to add contributors

Content type
Show options
  • Article

    CADTH Update Outlines Revisions To Biosimilar And Pharmaceutical Review Programs

    In its Common Drug Review (CDR) Update – Issue 133 (with further details in Revisions to CADTH's Biosimilar and Resubmission Processes, Other Administrative Changes...
    CanadaFood, Drugs, Healthcare, Life Sciences
    Smart & Biggar
    Smart & Biggar
  • Article

    Cannabis Act Under Senate Review

    The Government of Canada has proposed An Act respecting cannabis and to amend the Controlled Drugs and Substances Act, the Criminal Code and other Acts, which has passed first reading in the Senate.
    CanadaFood, Drugs, Healthcare, Life Sciences
    Smart & Biggar
    Smart & Biggar
  • Article

    Competition Bureau Publishes Final Updated Intellectual Property Enforcement Guidelines

    On March 13, 2019, the Competition Bureau ("Bureau") published the final version of its updated Intellectual Property Enforcement Guidelines (IPEGs).
    CanadaFood, Drugs, Healthcare, Life Sciences
    Smart & Biggar
    Smart & Biggar
  • Article

    Consultation On New Guidance For Foods Sold Through E-commerce (open Until July 8, 2022)

    Health Canada and the Canadian Food Inspection Agency (CFIA) are seeking feedback to inform their development of voluntary guidance for businesses when selling food and beverages to consumers through e-commerce.
    CanadaFood, Drugs, Healthcare, Life Sciences
    Miller Thomson
    Miller Thomson
  • Article

    Consultations Open As Health Canada Continues Roll-Out Of Healthy Eating Initiatives

    Partially hydrogenated oils, sugars, sodium and saturated fats are caught in the cross-hairs as Health Canada moves forward on its Healthy Eating Strategy.
    CanadaFood, Drugs, Healthcare, Life Sciences
    Torys
    Torys
  • Article

    Draft Guidelines Published By The Patented Medicine Prices Review Board

    The Patented Medicine Prices Review Board recently published draft Guidelines to replace the current Compendium of Policies, Guidelines and Procedures, leading up to the coming into force of the amended ...
    CanadaFood, Drugs, Healthcare, Life Sciences
    Fasken
    Fasken
  • Article

    Government Of Canada Announces Creation Of Canadian Drug Agency

    On December 18, 2023, the Minister of Health announced the creation of the Canadian Drug Agency. According to the announcement...
    CanadaFood, Drugs, Healthcare, Life Sciences
    Smart & Biggar
    Smart & Biggar
  • Article

    Health Canada And U.S. FDA Agree To Establish Information Sharing Program For Generic Drug Submission Reviews

    Health Canada and the U.S. Food and Drug Administration (FDA) have created a program to support the establishment of a Request for Information Sharing (RIS) program...
    CanadaFood, Drugs, Healthcare, Life Sciences
    Smart & Biggar
    Smart & Biggar
  • Article

    Health Canada Announced The Publication Of Blood Regulations And Amendments To The Food And Drugs Act And Regulations In The Canada Gazette - Intellectual Property Weekly Abstracts Bulletin (Week Of November 11, 2013)

    Health Canada announced the Publication of Blood Regulations and amendments to the Food and Drugs Act and Regulations in the Canada Gazette, Part II
    CanadaFood, Drugs, Healthcare, Life Sciences
    Borden Ladner Gervais LLP
    Borden Ladner Gervais LLP
  • Article

    Health Canada Finalizes Food Processing Aid Policy And Guidance

    The Food Directorate has released its finalized policy for issuing Interim Letter of No Objection (iLONO) for food processing aids required by the CFIA.
    CanadaFood, Drugs, Healthcare, Life Sciences
    Gowling WLG
    Gowling WLG
  • Article

    Health Canada Issues Front-Of-Pack Labeling Regulation

    The new FOP features a magnifying glass and a dual language warning if a product is "high" in saturated fat, sugars, and/or sodium.
    CanadaFood, Drugs, Healthcare, Life Sciences
    Keller & Heckman
    Keller & Heckman
  • Article

    Health Canada TPD, BRDD And NNHPD Annual Performance Reports Released

    The Therapeutic Products Directorate (TPD), the Biologic and Radiopharmaceutical Drugs Directorate (BRDD), and the Natural and Non-Prescription Health Products Directorate (NNHPD) ...
    CanadaFood, Drugs, Healthcare, Life Sciences
    Smart & Biggar
    Smart & Biggar
  • Article

    Life Signs — Life Sciences Legal Trends In Canada

    This publication is the most recent effort on our part to share with our clients and friends insights into some of the issues that we address in our efforts to advise the sector.
    CanadaFood, Drugs, Healthcare, Life Sciences
    Borden Ladner Gervais LLP
    Borden Ladner Gervais LLP
  • Article

    Market Access: National Pharmacare, OHIP+, Costco Rebates

    On June 12, the Advisory Council on the Implementation of National Pharmacare released its final report which recommends that Canada implement a universa
    CanadaFood, Drugs, Healthcare, Life Sciences
    Smart & Biggar
    Smart & Biggar
  • Article

    Matt Maurer Quoted In Law Times On The Heightened Stock Market Interest In Cannabis

    Chair of the Cannabis Law Group, Matt Maurer, was quoted in "Heightened stock market interest in cannabis persists" in Law Times on January 15, 2018.
    CanadaFood, Drugs, Healthcare, Life Sciences
    Minden Gross LLP
    Minden Gross LLP
  • Article

    Matt Maurer Speaks To Business Of Cannabis About Ontario's New Cannabis Laws

    Matt and Jay discussed a wide variety of topics, from private retail, to farm gate, to new consumption rules.
    CanadaFood, Drugs, Healthcare, Life Sciences
    Torkin Manes LLP
    Torkin Manes LLP
  • Article

    New Pilot Program To Streamline Cosmetic And Drug Imports

    Health Canada recently announced the start of a one-year Advance Notice of Importation Process pilot program.
    CanadaFood, Drugs, Healthcare, Life Sciences
    Torys
    Torys
  • Article

    Ontario Human Rights Commission Posts Q And A On Cannabis And The Human Rights Code

    With legalization on Ontario's doorstep, the Ontario Human Rights Commission has issued a new policy discussing the impact of legal cannabis on human rights issues in the province.
    CanadaFood, Drugs, Healthcare, Life Sciences
    Cassels
    Cassels
  • Article

    PMPRB News: "Significant Changes" To Be Made To Draft Pricing Guidelines

    On April 2, 2020, the Patented Medicine Prices Review Board (PMPRB) published a message from the Chairperson regarding the results of its consultation on the draft Guidelines operationalizing the...
    CanadaFood, Drugs, Healthcare, Life Sciences
    Smart & Biggar
    Smart & Biggar
  • Article

    PMPRB Releases New Draft Guidelines For Comment

    Following its Phase 2 Consultations, on December 19, 2025, the Patented Medicine Prices Review Board (PMPRB) released its new Draft Guidelines and accompanying Overview.
    CanadaFood, Drugs, Healthcare, Life Sciences
    Smart & Biggar
    Smart & Biggar
  • Showing 121–140 of 3511 results

    PreviousNext
    Legal Intelligence Newsletters: sign up for the latest legal and regulatory news on your chosen topics